Skip to main content
Log in

Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) and mechanisms (inhibition of endocannabinoid enzymatic degradation) potentially beneficial for colon carcinogenesis. Thus, we investigated its possible chemopreventive effect in the model of colon cancer induced by azoxymethane (AOM) in mice. AOM treatment was associated with aberrant crypt foci (ACF, preneoplastic lesions), polyps, and tumour formation, up-regulation of phospho-Akt, iNOS and COX-2 and down-regulation of caspase-3. Cannabidiol-reduced ACF, polyps and tumours and counteracted AOM-induced phospho-Akt and caspase-3 changes. In colorectal carcinoma cell lines, cannabidiol protected DNA from oxidative damage, increased endocannabinoid levels and reduced cell proliferation in a CB1-, TRPV1- and PPARγ-antagonists sensitive manner. It is concluded that cannabidiol exerts chemopreventive effect in vivo and reduces cell proliferation through multiple mechanisms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61:212–236

    Article  PubMed  Google Scholar 

  2. Markowitz SD, Bertagnolli MM (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med 361:2449–2460

    Article  PubMed  CAS  Google Scholar 

  3. Half E, Arber N (2009) Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother 10:211–219

    Article  PubMed  CAS  Google Scholar 

  4. Di Marzo V (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7:438–455

    Article  PubMed  Google Scholar 

  5. Pertwee RG (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br J Pharmacol 156:397–411

    Article  PubMed  CAS  Google Scholar 

  6. Izzo AA, Aviello G, Petrosino S, Orlando P, Morsicano G, Lutz B, Borrelli F, Capasso R, Nigam S, Capasso F et al (2008) Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon. J Mol Med 86:89–98

    Article  PubMed  CAS  Google Scholar 

  7. Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P et al (2008) Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. Clin Cancer Res 14:7691–7700

    Article  PubMed  CAS  Google Scholar 

  8. Wang D, Wang H, Ning W, Backlund MG, Dey SK, DuBois RN (2008) Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res 68:6468–6476

    Article  PubMed  CAS  Google Scholar 

  9. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R (2009) Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30:515–527

    Article  PubMed  CAS  Google Scholar 

  10. Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA (2008) Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br J Pharmacol 154:1001–1008

    Article  PubMed  CAS  Google Scholar 

  11. Cluny NL, Naylor RJ, Whittle BA, Javid FA (2011) The effects of cannabidiolic acid and cannabidiol on contractility of the gastrointestinal tract of Suncus murinus. Arch Pharm Res 34:1509–1517

    Article  PubMed  CAS  Google Scholar 

  12. Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Macello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V et al (2009) Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med 87:1111–1121

    Article  PubMed  CAS  Google Scholar 

  13. Jamontt JM, Molleman A, Pertwee RG, Parsons ME (2010) The effects of delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis. Br J Pharmacol 160:712–723

    Article  PubMed  CAS  Google Scholar 

  14. Terzić J, Grivennikov S, Karin E, Karin M (2010) Inflammation and colon cancer. Gastroenterology 138:2101–2114

    Article  PubMed  Google Scholar 

  15. De Petrocellis L, Ligresti A, Moriello AS, Allarà M, Bisogno T, Petrosino S, Stott CG, Di Marzo V (2011) Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol 163:1479–1494

    Article  PubMed  Google Scholar 

  16. Izzo AA, Sharkey KA (2010) Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 126:21–38

    Article  PubMed  CAS  Google Scholar 

  17. Klaunig JE, Wang Z, Pu X, Zhou S (2011) Oxidative stress and oxidative damage in chemical carcinogenesis. Toxicol Appl Pharmacol 254:86–99

    Article  PubMed  CAS  Google Scholar 

  18. Fukuyama R, Niculaita R, Ng KP, Obusez E, Sanchez J, Kalady M, Aung PP, Casey G, Sizemore N (2008) Mutated in colorectal cancer, a putative tumor suppressor for serrated colorectal cancer, selectively represses beta-catenin-dependent transcription. Oncogene 27:6044–6055

    Article  PubMed  CAS  Google Scholar 

  19. Dunn EF, Iida M, Myers RA, Campbell DA, Hintz KA, Armstrong EA, Li C, Wheeler DL (2011) Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene 30:561–574

    Article  PubMed  CAS  Google Scholar 

  20. Boivin GP, Washington K, Yang K, Ward JM, Pretlow TP, Russell R, Besselsen DG, Godfrey VL, Doetschman T, Dove WF et al (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124:762–777

    Article  PubMed  Google Scholar 

  21. Aviello G, Rowland I, Gill CI, Acquaviva AM, Capasso F, McCann M, Capasso R, Izzo AA, Borrelli F (2010) Anti-proliferative effect of rhein, an anthraquinone isolated from Cassia species, on Caco-2 human adenocarcinoma cells. J Cell Mol Med 14:2006–2014

    Article  PubMed  CAS  Google Scholar 

  22. Massi P, Vaccani A, Bianchessi S, Costa B, Macchi P, Parolaro D (2006) The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells. Cell Mol Life Sci 63:2057–2066

    Article  PubMed  CAS  Google Scholar 

  23. Ramer R, Merkord J, Rohde H, Hinz B (2010) Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1. Biochem Pharmacol 79:955–966

    Article  PubMed  CAS  Google Scholar 

  24. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318:1375–1387

    Article  PubMed  CAS  Google Scholar 

  25. Shrivastava A, Kuzontkoski PM, Groopman J, Prasad A (2011) Cannabidiol induces programmed cell death in breast cancer cells by coordinating the crosstalk between apoptosis and autophagy. Mol Cancer Ther 10:1161–1172

    Article  PubMed  CAS  Google Scholar 

  26. Kim R (2005) Recent advances in understanding the cell death pathways activated by anticancer therapy. Cancer 103:1551–1560

    Article  PubMed  CAS  Google Scholar 

  27. Sheng H, Shao J, Townsend CM Jr, Evers BM (2003) Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 52:1472–1478

    Article  PubMed  CAS  Google Scholar 

  28. Wang Q, Wang X, Hernandez A, Kim S, Evers BM (2001) Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation. Gastroenterology 120:1381–1392

    Article  PubMed  CAS  Google Scholar 

  29. Greenhough A, Patsos HA, Williams AC, Paraskeva C (2007) The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 121:2172–2180

    Article  PubMed  CAS  Google Scholar 

  30. Rao CV (2004) Nitric oxide signaling in colon cancer chemoprevention. Mutat Res 555:107–119

    Article  PubMed  CAS  Google Scholar 

  31. Wu WK, Sung JJ, Lee CW, Yu J, Cho CH (2010) Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 295:7–16

    Article  PubMed  CAS  Google Scholar 

  32. Wiepz GJ, Edwin F, Patel T, Bertics PJ (2006) Methods for determining the proliferation of cells in response to EGFR ligands. Methods Mol Biol 327:179–187

    PubMed  CAS  Google Scholar 

  33. Izzo AA, Camilleri M (2009) Cannabinoids in intestinal inflammation and cancer. Pharmacol Res 60:117–125

    Article  PubMed  CAS  Google Scholar 

  34. Ligresti A, Bisogno T, Matias I, De Petrocellis L, Cascio MG, Cosenza V, D’argenio G, Scaglione G, Bifulco M, Sorrentini I et al (2003) Possible endocannabinoid control of colorectal cancer growth. Gastroenterology 125:677–687

    Article  PubMed  CAS  Google Scholar 

  35. O’Sullivan SE, Sun Y, Bennett AJ, Randall MD, Kendall DA (2009) Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol 612:61–68

    Article  PubMed  Google Scholar 

  36. Osawa E, Nakajima A, Wada K, Ishimine S, Fujisawa N, Kawamori T, Matsuhashi N, Kadowaki T, Ochiai M, Sekihara H et al (2003) Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology 124:361–367

    Article  PubMed  CAS  Google Scholar 

  37. Alhamoruni A, Lee AC, Wright KL, Larvin M, O’Sullivan SE (2010) Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. J Pharmacol Exp Ther 335:92–102

    Article  PubMed  CAS  Google Scholar 

  38. Kim CS, Park WH, Park JY, Kang KH, Kim M, Kawada T, Han I, Yu R (2004) Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 7:267–273

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

GA is grateful to Nexus award “Marcello Tonini”.

Conflict of interest

This work was partly supported by GW Pharmaceuticals (UK).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Vincenzo Di Marzo or Angelo A. Izzo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aviello, G., Romano, B., Borrelli, F. et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med 90, 925–934 (2012). https://doi.org/10.1007/s00109-011-0856-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-011-0856-x

Keywords

Navigation